To date, the phenotype spectrum of de novo ATP1A1 pathogenic variants has included neurodevelopmental disorders (including developmental delay, autism spectrum disorders, and epilepsy), emotional disorders, sleep disorders, and HSP. The gene discussed is ATP1A1; the disease is Global developmental delay.